MBX Biosciences, Inc.
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 262.15M | 277.06M | 55.26M | 70.32M | 80.68M |
| Total Receivables | 682.00K | 858.00K | 164.00K | 199.00K | 208.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.65M | 2.41M | 3.13M | 2.01M | 2.45M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 803.00K | 838.00K | 242.00K | 168.00K | 133.00K |
| Total Current Assets | 267.29M | 281.17M | 58.80M | 72.70M | 83.47M |
|
|
|||||
| Total Current Assets | 267.29M | 281.17M | 58.80M | 72.70M | 83.47M |
| Net Property, Plant & Equipment | 1.20M | 1.18M | 1.28M | 880.00K | 665.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 50.00K | 50.00K | 2.80M | 1.74M | 50.00K |
| Total Assets | 268.54M | 282.40M | 62.88M | 75.32M | 84.18M |
|
|
|||||
| Total Accounts Payable | 5.34M | 5.00M | 3.22M | 3.20M | 1.39M |
| Total Accrued Expenses | 5.55M | 5.75M | 4.82M | 2.34M | 2.38M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 171.00K | 166.00K | 162.00K | 157.00K | 153.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.05M | 10.92M | 8.20M | 5.70M | 3.93M |
|
|
|||||
| Total Current Liabilities | 11.05M | 10.92M | 8.20M | 5.70M | 3.93M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 44.00K | 87.00K | 129.00K | 171.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 42.00K | 68.00K | 125.00K | 185.00K | 194.00K |
| Total Liabilities | 11.09M | 11.03M | 8.41M | 6.01M | 4.29M |
|
|
|||||
| Common Stock & APIC | 394.89M | 393.18M | 5.91M | 4.88M | 3.06M |
| Retained Earnings | -137.51M | -121.92M | -103.78M | -87.92M | -75.58M |
| Treasury Stock & Other | 55.00K | 106.00K | -15.00K | -3.00K | 60.00K |
| Total Common Equity | 257.44M | 271.37M | -97.89M | -83.05M | -72.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 152.36M | 152.36M | 152.36M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 152.36M | 152.36M | 152.36M |
|
|
|||||
| Total Common Equity | 257.44M | 271.37M | -97.89M | -83.05M | -72.47M |
| Total Preferred Equity | -- | -- | 152.36M | 152.36M | 152.36M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 257.44M | 271.37M | 54.47M | 69.31M | 79.89M |
|
|
|||||